An oriented phase-II trial of d-Trp6-LH-RH in patients with prostatic carcinoma

G. Mathé, M. L. Vovan, J. Duchier, J. L. Misset, P. Morin, R. Keiling, L. Schwarzenberg, P. Kerbrat, E. Achille, J. C. Tronc, D. Machover, J. P. Fendler, E. Pappo, R. Metz, G. Prévot, A. M. Comaru-Schally, Andrew V Schally

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

An oriented phase II trial of D-Trp6-LH-RH was conducted according to Gehan's statistical method on 25 patients suffering from prostatic carcinoma. LH and testosterone serum levels decreased rapidly. Pain disappeared during the third month in 14 out of the 21 patients and markedly decreased in 5. Prostatism completely regressed in 10 out of the 22 subjects presenting it and markedly decreased in 9. Prostate hypertrophy regressed as shown by ultrasonography, in 84% and by more than 50% in 37% of the patients. The overall regression rate of bone scintigraphy images was 43%; a regression of more than 50% was only registered in 12.5% of the patients; this may be explained by the long time which is necessary before bone image disappearance occurs. Prostatic acid phosphatase levels regressed in 75% and by more than 50% in 66.7% of the patients.

Original languageEnglish
Pages (from-to)119-122
Number of pages4
JournalMedical Oncology and Tumor Pharmacotherapy
Volume1
Issue number2
DOIs
StatePublished - Jun 1 1984
Externally publishedYes

Fingerprint

Gonadotropin-Releasing Hormone
Carcinoma
Prostatism
Bone and Bones
Radionuclide Imaging
Hypertrophy
Testosterone
Prostate
Ultrasonography
Pain
Serum

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)
  • Oncology
  • Medicine(all)

Cite this

An oriented phase-II trial of d-Trp6-LH-RH in patients with prostatic carcinoma. / Mathé, G.; Vovan, M. L.; Duchier, J.; Misset, J. L.; Morin, P.; Keiling, R.; Schwarzenberg, L.; Kerbrat, P.; Achille, E.; Tronc, J. C.; Machover, D.; Fendler, J. P.; Pappo, E.; Metz, R.; Prévot, G.; Comaru-Schally, A. M.; Schally, Andrew V.

In: Medical Oncology and Tumor Pharmacotherapy, Vol. 1, No. 2, 01.06.1984, p. 119-122.

Research output: Contribution to journalArticle

Mathé, G, Vovan, ML, Duchier, J, Misset, JL, Morin, P, Keiling, R, Schwarzenberg, L, Kerbrat, P, Achille, E, Tronc, JC, Machover, D, Fendler, JP, Pappo, E, Metz, R, Prévot, G, Comaru-Schally, AM & Schally, AV 1984, 'An oriented phase-II trial of d-Trp6-LH-RH in patients with prostatic carcinoma', Medical Oncology and Tumor Pharmacotherapy, vol. 1, no. 2, pp. 119-122. https://doi.org/10.1007/BF02934983
Mathé, G. ; Vovan, M. L. ; Duchier, J. ; Misset, J. L. ; Morin, P. ; Keiling, R. ; Schwarzenberg, L. ; Kerbrat, P. ; Achille, E. ; Tronc, J. C. ; Machover, D. ; Fendler, J. P. ; Pappo, E. ; Metz, R. ; Prévot, G. ; Comaru-Schally, A. M. ; Schally, Andrew V. / An oriented phase-II trial of d-Trp6-LH-RH in patients with prostatic carcinoma. In: Medical Oncology and Tumor Pharmacotherapy. 1984 ; Vol. 1, No. 2. pp. 119-122.
@article{8d7cc1db53f8489abdbc084b6a2e4746,
title = "An oriented phase-II trial of d-Trp6-LH-RH in patients with prostatic carcinoma",
abstract = "An oriented phase II trial of D-Trp6-LH-RH was conducted according to Gehan's statistical method on 25 patients suffering from prostatic carcinoma. LH and testosterone serum levels decreased rapidly. Pain disappeared during the third month in 14 out of the 21 patients and markedly decreased in 5. Prostatism completely regressed in 10 out of the 22 subjects presenting it and markedly decreased in 9. Prostate hypertrophy regressed as shown by ultrasonography, in 84{\%} and by more than 50{\%} in 37{\%} of the patients. The overall regression rate of bone scintigraphy images was 43{\%}; a regression of more than 50{\%} was only registered in 12.5{\%} of the patients; this may be explained by the long time which is necessary before bone image disappearance occurs. Prostatic acid phosphatase levels regressed in 75{\%} and by more than 50{\%} in 66.7{\%} of the patients.",
author = "G. Math{\'e} and Vovan, {M. L.} and J. Duchier and Misset, {J. L.} and P. Morin and R. Keiling and L. Schwarzenberg and P. Kerbrat and E. Achille and Tronc, {J. C.} and D. Machover and Fendler, {J. P.} and E. Pappo and R. Metz and G. Pr{\'e}vot and Comaru-Schally, {A. M.} and Schally, {Andrew V}",
year = "1984",
month = "6",
day = "1",
doi = "10.1007/BF02934983",
language = "English",
volume = "1",
pages = "119--122",
journal = "Medical Oncology",
issn = "1357-0560",
publisher = "Humana Press",
number = "2",

}

TY - JOUR

T1 - An oriented phase-II trial of d-Trp6-LH-RH in patients with prostatic carcinoma

AU - Mathé, G.

AU - Vovan, M. L.

AU - Duchier, J.

AU - Misset, J. L.

AU - Morin, P.

AU - Keiling, R.

AU - Schwarzenberg, L.

AU - Kerbrat, P.

AU - Achille, E.

AU - Tronc, J. C.

AU - Machover, D.

AU - Fendler, J. P.

AU - Pappo, E.

AU - Metz, R.

AU - Prévot, G.

AU - Comaru-Schally, A. M.

AU - Schally, Andrew V

PY - 1984/6/1

Y1 - 1984/6/1

N2 - An oriented phase II trial of D-Trp6-LH-RH was conducted according to Gehan's statistical method on 25 patients suffering from prostatic carcinoma. LH and testosterone serum levels decreased rapidly. Pain disappeared during the third month in 14 out of the 21 patients and markedly decreased in 5. Prostatism completely regressed in 10 out of the 22 subjects presenting it and markedly decreased in 9. Prostate hypertrophy regressed as shown by ultrasonography, in 84% and by more than 50% in 37% of the patients. The overall regression rate of bone scintigraphy images was 43%; a regression of more than 50% was only registered in 12.5% of the patients; this may be explained by the long time which is necessary before bone image disappearance occurs. Prostatic acid phosphatase levels regressed in 75% and by more than 50% in 66.7% of the patients.

AB - An oriented phase II trial of D-Trp6-LH-RH was conducted according to Gehan's statistical method on 25 patients suffering from prostatic carcinoma. LH and testosterone serum levels decreased rapidly. Pain disappeared during the third month in 14 out of the 21 patients and markedly decreased in 5. Prostatism completely regressed in 10 out of the 22 subjects presenting it and markedly decreased in 9. Prostate hypertrophy regressed as shown by ultrasonography, in 84% and by more than 50% in 37% of the patients. The overall regression rate of bone scintigraphy images was 43%; a regression of more than 50% was only registered in 12.5% of the patients; this may be explained by the long time which is necessary before bone image disappearance occurs. Prostatic acid phosphatase levels regressed in 75% and by more than 50% in 66.7% of the patients.

UR - http://www.scopus.com/inward/record.url?scp=0021134828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021134828&partnerID=8YFLogxK

U2 - 10.1007/BF02934983

DO - 10.1007/BF02934983

M3 - Article

C2 - 6242478

AN - SCOPUS:0021134828

VL - 1

SP - 119

EP - 122

JO - Medical Oncology

JF - Medical Oncology

SN - 1357-0560

IS - 2

ER -